Litcius/Paper detail

Millipore xMap® Luminex (HATMAG-68K): An Accurate and Cost-Effective Method for Evaluating Alzheimer's Biomarkers in Cerebrospinal Fluid

Erika Oliveira Hansen, Natália Silva Dias, Ivonne Carolina Bolaños Burgos, Mônica Vieira Costa, Andréa Teixeira‐Carvalho, Antônio Lúcio Teixeira, Izabela Guimarães Barbosa, Lorena Aline Valu dos Santos, Daniela Valadão Rosa, Aloísio Joaquim Freitas Ribeiro, Bernardo de Mattos Viana, Maria Aparecida Camargos Bicalho

2021Frontiers in Psychiatry17 citationsDOIOpen Access PDF

Abstract

Background: Alzheimer's disease (AD) biomarkers are of great relevance in clinical research, especially after the AT(N) framework. They enable early diagnosis, disease staging and research with new promising drugs, monitoring therapeutic response. However, the high cost and low availability of the most well-known methods limits their use in low and medium-income countries. In this context, Millipore xMap ® Luminex may be a cost-effective alternative. In our study, using INNOTEST ® as reference, we assess the diagnostic accuracy of Millipore xMap ® and propose a cutoff point for AD. Methods: We performed lumbar puncture of seven older individuals with clinically defined AD, 17 with amnestic mild cognitive impairment (aMCI) and 11 without objective cognitive impairment-control group (CG). Cerebrospinal fluid (CSF) biomarkers concentrations for aB42, p-Tau, and t-Tau were measured by INNOTEST ® and Millipore xMap ® , and then the techniques were compared to assess the diagnostic accuracy of the new test and to define a cutoff. Results: INNOTEST ® and Millipore xMap ® measurements showed all correlations >0.8 for the same biomarker, except for t-Tau that was 0.66. Millipore xMap ® measurements showed a robust accuracy for all biomarkers, with AUC higher than 0.808 (t-Tau), and the best for Aβ42 (AUC = 0.952). The most accurate cutoffs were found at 1012.98 pg/ml (Aβ42), 64.54 pg/ml (p-tau), 3251.81 pg/ml (t-tau), 3.370 (t-Tau/Aβ42), and 0.059 (p-Tau/Aβ42). Conclusion: Given its good accuracy and cost-effectiveness, Milliplex xMap ® tests seems a reliable and promising tool, especially for low and middle-income countries.

Topics & Concepts

MedicineCerebrospinal fluidBiomarkerContext (archaeology)Cognitive impairmentLumbar punctureCutoffInternal medicineGastroenterologyDiseaseChemistryBiochemistryPaleontologyQuantum mechanicsPhysicsBiologyAlzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchTraumatic Brain Injury and Neurovascular Disturbances
Millipore xMap® Luminex (HATMAG-68K): An Accurate and Cost-Effective Method for Evaluating Alzheimer's Biomarkers in Cerebrospinal Fluid | Litcius